This Article Full Text Full Text (PDF) CME: Take the course for this article: Stroke: December 2008, Volume 39, Number 12 All Versions of this Article: 39/12/3193    most recent STROKEAHA.107.513408v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Kraemer, M. Articles by Berlit, P. Search for Related Content PubMed PubMed Citation Articles by Kraemer, M. Articles by Berlit, P. Related Collections Stroke in Children and the Young Other Stroke Treatment - Medical By-pass procedures Other Stroke Treatment - Surgical

(Stroke. 2008;39:3193.)
© 2008 American Heart Association, Inc.

Original Contributions

Moyamoya Disease in Europeans

From the Departments of Neurology (M.K., P.B.) and Neurosurgery (W.H.), Alfried Krupp von Bohlen und Halbach Hospital, Essen, Germany.

Correspondence to Markus Kraemer, MD, Department of Neurology, Alfried Krupp von Bohlen und Halbach Hospital, Alfried-Krupp-Str 21, D-45117 Essen, Germany. E-mail markus.kraemer1977{at}gmx.de

Background and Purpose— We describe the clinical, diagnostic, and outcome features of a cohort of white patients with idiopathic moyamoya disease treated in a German institution.

Methods— Our cohort included 21 white patients with moyamoya disease. Clinical and diagnostic features were obtained by retrospective chart review; follow-up information and outcome were obtained prospectively. We used the Kaplan–Meier methods to estimate stroke risk by treatment status.

Results— The mean age at onset of symptoms was 31 years. The female predominance was 4.25:1. In our cohort, the initial symptom was a cerebral ischemic event in all patients. There was no patient with a hemorrhage at onset; only one patient experienced subarachnoidal hemorrhage in the further course of disease. The Kaplan–Meier risk for recurrent stroke was very high after the first ischemic event and smaller after angiographic diagnosis. The 5-year-Kaplan–Meier risk of recurrent stroke was 80.95% after the first ischemic event for all patients. Most subsequent ischemic events appeared in the first 2 years after symptom onset. Eleven patients (52.3%) underwent neurosurgical revascularizing procedures. After surgery, the Kaplan–Meier risk of perioperative or subsequent stroke was 27.27% within the first month and was stable thereafter.

Conclusion— Clinical features and course of moyamoya disease of whites analyzed in this German study are comparable to American results. Moyamoya disease in whites differs clearly from Asian moyamoya disease in timing of onset of vasculopathy and lower rate of hemorrhages.

Key Words: moyamoya disease • Europeans • revascularizing procedure • nonsurgical treatment